LOS ANGELES CAPITAL MANAGEMENT LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$537,588
-67.9%
28,748
-68.5%
0.00%
-71.4%
Q1 2023$1,676,695
-30.1%
91,373
-24.5%
0.01%
-41.7%
Q4 2022$2,397,839
+724.0%
121,103
+901.4%
0.01%
+500.0%
Q3 2022$291,000
-25.0%
12,093
+14.4%
0.00%
+100.0%
Q4 2021$388,000
+18.3%
10,5720.0%0.00%0.0%
Q3 2021$328,000
-43.7%
10,572
-42.4%
0.00%
-66.7%
Q2 2021$583,000
+49.5%
18,352
+4.5%
0.00%
+50.0%
Q1 2021$390,00017,5620.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$49,189,39517.79%
Euclidean Capital LLC 432,900$7,943,7156.97%
GREAT POINT PARTNERS LLC 1,355,151$24,867,0214.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 875,984$16,074,3063.02%
Trustees of Columbia University in the City of New York 80,580$1,478,6432.64%
Perceptive Advisors 2,291,608$42,051,0071.24%
Cormorant Asset Management, LP 650,000$11,9280.79%
Alphabet Inc. 540,270$9,913,9550.55%
Redmile Group, LLC 688,132$12,627,2220.55%
Orbimed Advisors 1,251,070$22,957,1350.45%
View complete list of RAPT THERAPEUTICS INC shareholders